ERBB2 and adenocarcinoma: An adenocarcinoma of the upper GI tract is considered Her2/neu positive if (a) at least five contiguous carcinoma cells are Her2/neu positive on endoscopic biopsies or (b) at least 10% of the tumour is Her2/neu positive on surgical specimens12.